Gold Stocks News:  Running Fox Resource (TSX V:RUN): Approves High Grade Gold Project

VANCOUVER, BRITISH COLUMBIA - February 23, 2011 (Investorideas.com newswire) Steven Schurman, P. Geol (US), CEO, Director, reports:
Running Fox Resources (TSX VENTURE:RUN; PINK SHEETS:RFXRF; FRANKFURT:C8Q) is pleased to report that it has received formal Toronto Stock Exchange - Venture approval for its agreement to acquire the remaining 50% of the its high grade Brett Gold Project, Running Fox will then own 100%.
The Teck Cominco smelter receipts for the net recovered grades for the whole bulk sample proved ore averaged 28 grams per tonne gold plus 64 grams per tonne silver.
A review of drilling results at the Brett Gold Project includes 16 metres of 35 grams per ton gold.

Brett Gold Property - from 43-101 Technical Report Table of Significant Intersections selected intercepts all over minimum width/grade, Gold values only, Silver To Be Determined

Hole # number	Grade oz Au/t	from feet	to feet	length feet	from meters	to meters	length in meters	Gold grade gms Au/mt
--------------------------------------------------------------------------------------------------------------------------------
86-04	0.253	34.51	39.01	4.49	10.52	11.89	1.37	8.66
--------------------------------------------------------------------------------------------------------------------------------
86-09	0.290	154.99	160.01	5.02	47.24	48.77	1.53	9.93
--------------------------------------------------------------------------------------------------------------------------------
86-10	0.125	146.00	150.98	4.99	44.50	46.02	1.52	4.28
--------------------------------------------------------------------------------------------------------------------------------
86-15	0.284	135.01	141.01	6.00	41.15	42.98	1.83	9.73
--------------------------------------------------------------------------------------------------------------------------------
86-16	0.175	185.99	197.01	11.02	56.69	60.05	3.36	5.99
--------------------------------------------------------------------------------------------------------------------------------
87-29	0.166	137.80	141.08	3.28	42.00	43.00	1.00	5.68
--------------------------------------------------------------------------------------------------------------------------------
87-29	0.737	149.77	178.05	28.28	45.65	54.27	8.62	25.24
--------------------------------------------------------------------------------------------------------------------------------
87-29	0.274	170.90	178.00	7.10	52.09	54.25	2.16	9.38
--------------------------------------------------------------------------------------------------------------------------------
87-30	0.144	263.00	273.00	10.00	80.16	83.21	3.05	4.93
--------------------------------------------------------------------------------------------------------------------------------
87-30	0.127	296.26	301.51	5.25	90.30	91.90	1.60	4.35
--------------------------------------------------------------------------------------------------------------------------------
87-30	0.092	311.90	329.00	17.10	95.07	100.28	5.21	3.15
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
87-36	0.063	149.93	175.03	25.10	45.70	53.35	7.65	2.16
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
87-37	0.104	212.90	234.60	21.70	64.89	71.51	6.61	3.56
--------------------------------------------------------------------------------------------------------------------------------
87-42	0.991	256.70	265.70	9.00	78.24	80.99	2.74	33.94
--------------------------------------------------------------------------------------------------------------------------------
87-45	0.169	216.50	221.50	5.00	65.99	67.51	1.52	5.79
--------------------------------------------------------------------------------------------------------------------------------
87-45	0.125	226.40	232.90	6.50	69.01	70.99	1.98	4.28
--------------------------------------------------------------------------------------------------------------------------------
7-46	0.119	93.40	98.10	4.70	28.47	29.90	1.43	4.08
--------------------------------------------------------------------------------------------------------------------------------
87-46	0.107	105.00	119.80	14.80	32.00	36.52	4.51	3.66
--------------------------------------------------------------------------------------------------------------------------------
87-46	0.074	137.96	188.98	51.02	42.05	57.60	15.55	2.53
--------------------------------------------------------------------------------------------------------------------------------
87-46	0.111	170.90	186.00	15.10	52.09	56.69	4.60	3.80
--------------------------------------------------------------------------------------------------------------------------------
87-46	0.133	259.19	279.04	19.85	79.00	85.05	6.05	4.55
--------------------------------------------------------------------------------------------------------------------------------
87-47	0.110	221.10	226.70	5.60	67.39	69.10	1.71	3.77
--------------------------------------------------------------------------------------------------------------------------------
87-47	0.980	245.10	248.10	3.00	74.71	75.62	0.91	33.56
--------------------------------------------------------------------------------------------------------------------------------
88-51	0.540	125.00	132.20	7.20	38.10	40.29	2.19	18.49
--------------------------------------------------------------------------------------------------------------------------------
88-61	0.082	148.29	153.22	4.92	45.20	46.70	1.50	2.81
--------------------------------------------------------------------------------------------------------------------------------
88-61	0.278	233.90	236.90	3.00	71.29	72.21	0.91	9.52
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
88-62	0.119	356.60	366.50	9.90	108.69	111.71	3.02	4.08
--------------------------------------------------------------------------------------------------------------------------------
88-67	0.091	332.19	337.11	4.92	101.25	102.75	1.50	3.12
--------------------------------------------------------------------------------------------------------------------------------
88-69	0.107	373.40	378.80	5.40	113.81	115.46	1.65	3.66
--------------------------------------------------------------------------------------------------------------------------------
88-73	0.168	505.25	509.84	4.59	154.00	155.40	1.40	5.75
--------------------------------------------------------------------------------------------------------------------------------
89-76	0.118	395.01	401.05	6.04	120.40	122.24	1.84	4.04
--------------------------------------------------------------------------------------------------------------------------------
89-78	0.041	235.89	257.48	21.59	71.90	78.48	6.58	1.40
--------------------------------------------------------------------------------------------------------------------------------
89-80	0.211	262.93	268.01	5.09	80.14	81.69	1.55	7.23
--------------------------------------------------------------------------------------------------------------------------------
89-80	0.197	322.87	325.69	2.82	98.41	99.27	0.86	6.75
--------------------------------------------------------------------------------------------------------------------------------
89-80	0.202	343.34	347.83	4.49	104.65	106.02	1.37	6.92
--------------------------------------------------------------------------------------------------------------------------------
89-82	0.185	323.00	332.41	9.42	98.45	101.32	2.87	6.34
--------------------------------------------------------------------------------------------------------------------------------
89-89	0.720	615.72	618.01	2.30	187.67	188.37	0.70	24.66
--------------------------------------------------------------------------------------------------------------------------------
89-89	0.280	611.61	618.01	6.40	186.42	188.37	1.95	9.59
--------------------------------------------------------------------------------------------------------------------------------
89-91	1.256	441.31	445.41	4.10	134.51	135.76	1.25	43.01
--------------------------------------------------------------------------------------------------------------------------------
89-91	0.726	441.31	450.66	9.35	134.51	137.36	2.85	24.86
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
89-92	1.590	427.00	430.74	3.74	130.15	131.29	1.14	54.45
--------------------------------------------------------------------------------------------------------------------------------
89-97	0.224	462.60	470.90	8.30	141.00	143.53	2.53	7.67
--------------------------------------------------------------------------------------------------------------------------------
R88-02	0.076	102.03	136.98	34.94	31.10	41.75	10.65	2.60
--------------------------------------------------------------------------------------------------------------------------------
R88-02	0.049	247.00	332.00	85.00	75.29	101.19	25.91	1.68
--------------------------------------------------------------------------------------------------------------------------------
R88-03	0.100	73.00	77.92	4.92	22.25	23.75	1.50	3.42
--------------------------------------------------------------------------------------------------------------------------------
R88-04	0.027	19.72	34.94	15.22	6.01	10.65	4.64	0.92
--------------------------------------------------------------------------------------------------------------------------------
R88-07	0.503	88.90	104.00	15.10	27.10	31.70	4.60	17.23
--------------------------------------------------------------------------------------------------------------------------------
R88-09	0.089	52.99	58.07	5.09	16.15	17.70	1.55	3.05
--------------------------------------------------------------------------------------------------------------------------------
R88-15	0.100	145.01	155.02	10.01	44.20	47.25	3.05	3.42
--------------------------------------------------------------------------------------------------------------------------------
R88-15	0.101	149.93	155.02	5.09	45.70	47.25	1.55	3.46
--------------------------------------------------------------------------------------------------------------------------------
R88-15	0.108	274.93	284.94	10.01	83.80	86.85	3.05	3.70
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
R88-17	0.224	55.00	80.00	25.00	16.76	24.38	7.62	7.67
--------------------------------------------------------------------------------------------------------------------------------
R88-17	0.462	385.01	405.02	20.01	117.35	123.45	6.10	15.82
--------------------------------------------------------------------------------------------------------------------------------
R88-16	0.074	75.00	185.00	110.00	22.86	56.39	33.53	2.53
--------------------------------------------------------------------------------------------------------------------------------
R88-18	0.165	221.46	225.07	3.61	67.50	68.60	1.10	5.65
--------------------------------------------------------------------------------------------------------------------------------
R88-18	0.228	245.08	254.92	9.84	74.70	77.70	3.00	7.81
--------------------------------------------------------------------------------------------------------------------------------
R88-18	0.088	294.95	304.95	10.01	89.90	92.95	3.05	3.01
--------------------------------------------------------------------------------------------------------------------------------
R88-19	0.270	135.00	140.00	5.00	41.15	42.67	1.52	9.25
--------------------------------------------------------------------------------------------------------------------------------
R88-19	0.113	135.01	149.93	14.93	41.15	45.70	4.55	3.87
--------------------------------------------------------------------------------------------------------------------------------
R88-19	0.110	195.05	199.97	4.92	59.45	60.95	1.50	3.77
--------------------------------------------------------------------------------------------------------------------------------
R88-21	0.124	50.03	54.95	4.92	15.25	16.75	1.50	4.25
--------------------------------------------------------------------------------------------------------------------------------
R88-22	0.244	314.96	330.05	15.09	96.00	100.60	4.60	8.36
--------------------------------------------------------------------------------------------------------------------------------
R88-22	0.084	315.00	406.00	91.00	96.01	123.75	27.74	2.88
--------------------------------------------------------------------------------------------------------------------------------
R88-22	0.106	364.17	383.86	19.69	111.00	117.00	6.00	3.63
--------------------------------------------------------------------------------------------------------------------------------
R88-23	0.042	183.73	209.97	26.25	56.00	64.00	8.00	1.44
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.097	34.94	40.03	5.09	10.65	12.20	1.55	3.32
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.087	60.04	64.96	4.92	18.30	19.80	1.50	2.98
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.030	98.43	144.36	45.93	30.00	44.00	14.00	1.03
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.054	225.00	320.00	95.00	68.58	97.54	28.96	1.85
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.102	260.01	264.93	4.92	79.25	80.75	1.50	3.49
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.072	274.93	280.02	5.09	83.80	85.35	1.55	2.47
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.089	280.02	284.94	4.92	85.35	86.85	1.50	3.05
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.227	288.71	291.99	3.28	88.00	89.00	1.00	7.77
--------------------------------------------------------------------------------------------------------------------------------
R88-24	0.112	305.12	310.04	4.92	93.00	94.50	1.50	3.84
--------------------------------------------------------------------------------------------------------------------------------
R88-25	0.050	324.80	360.89	36.09	99.00	110.00	11.00	1.71
--------------------------------------------------------------------------------------------------------------------------------
R88-30	0.124	80.05	84.97	4.92	24.40	25.90	1.50	4.25
--------------------------------------------------------------------------------------------------------------------------------
R88-31	0.058	62.34	101.71	39.37	19.00	31.00	12.00	1.99
--------------------------------------------------------------------------------------------------------------------------------
R88-32	0.136	65.00	120.00	55.00	19.81	36.58	16.76	4.66
--------------------------------------------------------------------------------------------------------------------------------
R88-32	0.171	70.05	74.97	4.92	21.35	22.85	1.50	5.86
--------------------------------------------------------------------------------------------------------------------------------
R88-33	0.113	20.01	24.93	4.92	6.10	7.60	1.50	3.87
--------------------------------------------------------------------------------------------------------------------------------
R88-33	0.050	104.99	129.92	24.93	32.00	39.60	7.60	1.71
--------------------------------------------------------------------------------------------------------------------------------
R88-33	0.088	399.93	405.02	5.09	121.9	123.45	1.55	3.01
--------------------------------------------------------------------------------------------------------------------------------
R88-34	0.083	400.26	410.10	9.84	122.00	125.00	3.00	2.84
--------------------------------------------------------------------------------------------------------------------------------
R93-11	0.197	130.00	140.00	10.00	39.62	42.67	3.05	6.75
--------------------------------------------------------------------------------------------------------------------------------
R93-12	1.840	115.00	120.00	5.00	35.05	36.58	1.52	63.01
--------------------------------------------------------------------------------------------------------------------------------
R93-12	1.210	140.00	145.00	5.00	42.67	44.20	1.52	41.44
--------------------------------------------------------------------------------------------------------------------------------
R93-12	0.382	130.00	150.00	20.00	39.62	45.72	6.10	13.09
--------------------------------------------------------------------------------------------------------------------------------
R93-12	0.208	200.00	210.00	10.00	60.96	64.01	3.05	7.12
--------------------------------------------------------------------------------------------------------------------------------
R93-12	0.113	175.00	210.00	35.00	53.34	64.01	10.67	3.87
--------------------------------------------------------------------------------------------------------------------------------
R93-16	0.692	120.00	125.00	5.00	36.58	38.10	1.52	23.70
--------------------------------------------------------------------------------------------------------------------------------
R93-17	0.408	105.00	110.00	5.00	32.00	33.53	1.52	13.97
--------------------------------------------------------------------------------------------------------------------------------
R93-17	2.750	125.00	130.00	5.00	38.10	39.62	1.52	94.18
--------------------------------------------------------------------------------------------------------------------------------
R93-17	1.640	125.00	135.00	10.00	38.10	41.15	3.05	56.16
--------------------------------------------------------------------------------------------------------------------------------
R93-19	1.045	100.00	155.00	55.00	30.48	47.24	16.76	35.79
--------------------------------------------------------------------------------------------------------------------------------
R93-19	0.283	175.00	180.00	5.00	53.34	54.86	1.52	9.69
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
87-TR4	1.840	6.40	10.99	4.59	1.95	3.35	1.40	63.01
--------------------------------------------------------------------------------------------------------------------------------
87-TR21	2.052	0.00	7.87	7.87	0.00	2.40	2.40	70.27
--------------------------------------------------------------------------------------------------------------------------------
87-TR21	0.372	0.00	7.87	7.87	0.00	2.40	2.40	12.74
--------------------------------------------------------------------------------------------------------------------------------
87-TR22	0.110	37.07	54.13	17.06	11.30	16.50	5.20	3.77
--------------------------------------------------------------------------------------------------------------------------------
93-TR770	0.370	0.00	18.24	18.24	0.00	5.56	5.56	12.67
--------------------------------------------------------------------------------------------------------------------------------
93-TR946	0.980	10.89	13.52	2.62	3.32	4.12	0.80	33.56
--------------------------------------------------------------------------------------------------------------------------------
93-TR957	2.650	19.23	20.77	1.54	5.86	6.33	0.47	90.75
--------------------------------------------------------------------------------------------------------------------------------
93-TR957	0.696	18.57	24.70	6.14	5.66	7.53	1.87	23.84
--------------------------------------------------------------------------------------------------------------------------------
93-TR988	0.549	54.49	57.28	2.79	16.61	17.46	0.85	18.80
--------------------------------------------------------------------------------------------------------------------------------

2004 Program
In addition to the intercepts in the table above, the 2004 drilling program intersected significant gold bearing intersections in 15 of the 17 holes drilled, notably:
DDH# 04-01 intersected 10.2 meters grading 5.28 grams per ton including 1.6 meters grading 29.6 grams per ton gold, and,
DDH# 04-02 intersected 11.6 meters grading 10.39 grams gold per ton including 3.1 meters grading 34.02 grams per ton gold; and,
Importantly, DDH# 04-12 intercepted 1.3 meters grading 176 grams per ton gold in a new shear zone.
This new zone, located on a tuffaceous bed, is located 53 metres east of the main shear zone and represents a totally new zone as none of the previous drill holes went as far east as this hole. The zone is cut off by several postmineral dikes in the core, possibly indicating the presence of a second parallel shear structure. If so, this would be the first confirmation of bonanza high-grade gold values (greater than one ounce per ton gold) on a parallel shear structure, opening the possibility that similar high-grade zones may be present, along the numerous other shears identified during surface work. The entire strike length of the new shear structure is unexplored as none of the previous drill holes were near its projection.
Also See "Top 40 Gold Intercepts" at http://www.foxgold.ca/images/40holes.jpg
The 2004 soil geochemical survey identified numerous and as yet untested gold in soil anomalies as much as 2,000 meters north of the Main Shear Zone drilling which appear to trend in the same northeast and northwest direction as the gold mineralization found in the shear zones around the Main Shear Zone. Gold mineralization found in a road cut 3,000 meters north of the Main Shear Zone drilling assayed 9.5 grams per ton gold.

Running Fox believes that these untested soil anomalies represent significant exploration targets that are similar in geology and grade of gold mineralization to that found around the Main Shear Zone.
Post transaction, Running Fox will have approx. 49 million shares outstanding.
The Company has recurring cash flow and after recent progress, very little debt.
In addition, the Company owns other assets.
Running Fox will be planning a 2011 exploration campaign at the Brett property that will also include drilling and trenching of soil anomalies, as the prior program opened up large areas for exploration and the development of additional gold bearing zones.
Complete maps, geochem, and drilling history are available for review/download on the Running Fox website.
The project has significant early stage block calculations on a small portion of one shear zone - and there are numerous shear zones, running under large undrilled geochem zones with good gold values over large areas, (see Geochem in Assessment Report).
Following further drilling a new 43-101 Technical Report will be requested that will include all drilling and a qualifying resource calculation.
See the brief 3D Geological and drillhole movie on website www.foxgold.ca.
To view the, 3D image of footwall, please click on the following link: http://media3.marketwire.com/docs/0221run.jpg
Steven Schurman, CEO, Professional Geologist (US), is the named Qualified Person for the technical contents of this news release.
Note: Source for all intercepts are 43-101 Technical Report, and Brett Gold Assessment Report available at www.foxgold.ca and on SEDAR.
On behalf of the Board of Directors: Steven Schurman, P. Geol (US), CEO, Director
The Company relies on legislation applicable to forward looking statements, seeking safe harbour.
Contact:
Steven Schurman, P. Geol (US)
Running Fox Resource Corp.
CEO, Director
1 303 619 5234 or 604 725 8868
www.foxgold.ca

Q&A Interview with BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX); Update on LibiGel Phase III Clinical Development Program

February 23, 2011 - (Investorideas.com newswire.com) Investorideas.com, an investor research portal covering leading sectors including biotech stocks and pharma stocks, presents the fourth in a series of Q&A interviews with Stephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX). Mr. Simes updates the investment community on recent milestones for its leading product in development, LibiGel (testosterone gel).

The first introductory Q&A can be found here:
http://www.investorideas.com/CO/BPAX/news/9211.asp
In this follow up, Stephen M. Simes, president and chief executive officer of BioSante Pharmaceuticals discusses recent developments with LibiGel (testosterone gel).
Interview
Q: Investorideas.com
Stephen, can you give us a quick summary of some of the company's recent milestones?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
The most recent milestone regarding LibiGel is a very positive LibiGel safety data update. We reported that the safety study's independent Data Monitoring Committee (DMC) took its fifth unblinded look at adverse events reported in the LibiGel safety study. For the fifth time, the DMC recommended continuing the LibiGel safety study as per FDA-agreed protocol without modification. This is a positive outcome since the DMC did not express to us any concern to date about the safety of LibiGel.
Q: Investorideas.com
Your company just recently announced t hat there has been positive safety data in your ongoing LibiGel Phase III clinical trials. Your news release states "with 2,869 women enrolled and over 3,000 women-years of exposure in its LibiGel Phase III cardiovascular and breast cancer safety study, there have been 17 adjudicated cardiovascular (CV) events, with a lower than anticipated event rate of approximately 0.57 percent. There have been eight breast cancers reported, a rate of approximately 0.27 percent." With those positive safety results how much closer to FDA approval does that make LibiGel?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
We are making excellent progress toward FDA approval in that our three LibiGel Phase III clinical studies are proceeding as per our plan. Our hope is to submit a new drug application (NDA) to the FDA for a LibiGel approval and launch in 2012. This is on the near-term horizon for us.
Q: Investorideas.com
Your company recently presented data at an International conference showing Female Sexual Dysfunction is a significant unmet medical need. Can you give us a summary of some the physician stats to back that up?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
To start, it is important to point out that there is no FDA-approved pharmaceutical product for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). Well over 80 percent of surveyed physicians told us that there is a need or a great need for an FDA-approved product for the treatment of female sexual dysfunction, a full 13 years after Viagra was approved for men. In fact, over 90 percent of surveyed physicians report that they currently prescribe products off-label (that is, products not FDA-approved) for the treatment of FSD. Interestingly the average gynecologist hears 37 non-solicited complaints about FSD per month. The unmet medical need is dramatic.
Q: Investorideas.com
You recently stated. "LibiGel remains the only product in the world in Phase III clinical development for the treatment of HSDD". Can you comment in more detail on the significance of that?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
As I mentioned, there is no FDA-approved pharmaceutical product for the treatment of HSDD. LibiGel is the only product in the world in Phase III clinical development for this indication. Therefore, we expect to be the first product to be FDA approved for HSDD!
Q: Investorideas.com
As the biotech sector is heating up again for investors, your company has received substantial media attention recently, in particular following your company reporting positive safety data from your late-stage study. The company plans to submit an application for LibiGel's approval to the Food and Drug Administration in 2012 - so what key developments are in the pipeline for investors and media to watch for from now to then?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
In the very near-term, we hope to announce completion of enrollment in our LibiGel efficacy trials. In addition, we will continue to report on data from our LibiGel safety study, even though we remain blinded to which therapy, LibiGel or placebo, the women in the study are taking. LibiGel is the main driver of value for BioSante in 2011, however, we also expect to update the public about our other products in development including Bio-T-Gel, our male testosterone gel, already licensed to TEVA, as well as our cancer vaccines in development.
About LibiGel®
LibiGel® is a gel formulation of testosterone in development that is quickly absorbed through the skin after a once-daily application of a pea-sized dose of gel on the upper arm, delivering testosterone to the bloodstream evenly over time and in a non-invasive and painless manner. Though generally characterized as a male hormone, testosterone also is present in women and its deficiency has been found to decrease libido or sex drive. In addition, studies have shown that testosterone therapy can increase bone density, raise energy levels and improve mood, in addition to boosting sexual desire and activity.
Currently, BioSante is conducting three Phase III clinical studies to demonstrate the safety and efficacy of LibiGel to increase sexual desire and satisfying sexual events and to decrease distress associated with the decreased desire. Two Phase III safety and efficacy trials that are underway are randomized, doubleblind, placebo-controlled trials which will enroll approximately 500 surgically menopausal women each for six-months of treatment. BioSante is conducting these trials under an FDA agreed special protocol assessment (SPA). In addition, BioSante has another SPA agreement with the FDA related to treatment of naturally menopausal women. The SPA process and agreement confirms the FDA's position that FSD and HSDD are true conditions that women experience, with measurable endpoints, that can be evaluated and which deserve therapeutic options. It also affirms that the FDA agrees that the LibiGel Phase III safety and efficacy clinical trial design, clinical endpoints, sample size, planned conduct and statistical analyses are acceptable to support regulatory approval. Further, it provides assurance that these agreed measures will serve as the basis for regulatory review and the decision by the FDA to approve an NDA for LibiGel.
About BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)
BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Visit the company profile on Investorideas.com: http://www.investorideas.com/CO/BPAX/
Or the company website www.biosantepharma.com to learn more about BioSante.
Request News & Updates from BioSante (NASDAQ: BPAX) on the Investorideas.com sign up page: http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia. Our leading biotech portal within our content umbrella, www.BiotechIndustryStocks.com, covers the biotech/pharma sector for independent investors with company profiles, news and stock directories.
Disclaimer: The following BioSante Pharmaceuticals, Inc company profile is a paid for submission (one thousand per month) Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions, company profile submissions and online advertising. http://www.investorideas.com/About/Disclaimer.asp
Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "potential," "could," "can," "believe," "intends," "continue," "plans," "expects," "anticipates," "estimates," "may," other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
For info about BioSante Pharmaceuticals, Inc
Contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953; tswanson@troutgroup.com
For Additional Information about Investorideas.com:
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

New Energy Stocks Group on Linkedin.com

Investorideas.com has created a new group for investors to connect with publicly traded oil and gas stocks on the TSX, OTC, NASDAQ, NYSE and global stock exchanges .

Discuss energy stocks as oil prices surge . 

 
Energy stocks ; News and Info on Oil and Gas Stocks
http://www.linkedin.com/e/ez47wj-gkhh3aly-4r/vgh/3799535/


About InvestorIdeas.com:

Investor Ideas is a global financial media online destination specialized in sector investing content.
The oil and gas stocks directory features over seven hundred stocks listed on the TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. The directory also features a section on Bakken stocks and oil sands stocks.
Preview the directory here: http://www.investorideas.com/OGSN/Stock_List.asp


Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities.

Electric Car, Natural Gas Vehicle Stocks Profile; EVCARCO (OTCBB: EVCA)

EVCARCO (OTCBB: EVCA) to Sell Class 3-5 Commercial Compressed Natural Gas Powered Trucks at Its Green Auto Dealerships

February 22, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a leading global investor and industry portal covering the green and renewable energy sector releases the company profile for electric car and natural gas vehicle stock, EVCARCO (OTCBB: EVCA).

Company Snapshot
EVCARCO (OTC.BB:EVCA) - Green , Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles.
Recent News
EVCARCO, Inc. (OTCBB: EVCA) Accepts Invitation to Exhibit at the Ft. Worth and Dallas Auto Shows
FT. WORTH, TX - February 18, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO (OTCBB:EVCA) (Pinksheets:EVCA) announced today that it will be exhibiting the Company's current green vehicle offerings at the Ft. Worth Auto Show, being held March 17th-20th at the Ft. Worth Convention Center and the Dallas Auto Show, being held on April 7th-10th at the Dallas Convention Center. EVCARCO's exhibits will be located in the Green Exhibitor Section dedicated to eco-friendly products.
Full news: http://www.investorideas.com/CO/EVCA/news/2011/02181.asp
EVCARCO (OTCBB: EVCA) to Sell Class 3-5 Commercial Compressed Natural Gas Powered Trucks at Its Green Auto Dealerships
FT. WORTH, TX - February 15, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO (OTCBB: EVCA) announced today that it will sell CNG powered Foton MD 3000 medium-duty class 3-5 trucks at its green auto dealerships. Foton Motor Co. is the largest commercial vehicle manufacturer in China, its existing assets are in excess of 5 Billion Dollars U.S. and they have a staff of 28,000 employees. Foton has the capacity to produce up to 26,000 units of the Foton MD 3000 medium-duty class 3-5 trucks a year.
Full news : http://www.investorideas.com/CO/EVCA/news/2011/02151.asp
Market Snapshot

• Dow 12,204.09 -187.16 -1.51%
• Nasdaq 2,762.04 -71.91 -2.54%
• S&P 500 1,315.39 -27.62 -2.06%
• 10 Yr Bond(%) 3.4770% -0.1120
• Oil 91.72 +5.65 +6.55%
• Gold 1,399.30 +10.30 +0.74%

Research electric car stocks and green auto stocks, lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensates the site 500,000 144 shares in lieu of cash compensation.
Contact EVCARCO (OTC.BB:EVCA)-
Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-571-1624
To become a showcase company, contact us below.
For more information contact:
Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com

Visit the EVCA showcase profile at Investorideas.com
Request News and Info on EVCA
Disclosure, Disclaimer/ EVCA is a paid advertising client on Investorideas.com and our renewable energy portals (500,000 144 shares).

Mining Stocks; YALE (TSX-V: YLL) FINALIZES OPTION FOR THE CAROL PROPERTY, SONORA STATE

February 22, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report that it has signed a formal Agreement with El Condor Minerals Inc. for the option to earn a 70% interest in Yale�s wholly owned Carol Property located in southern Sonora State, Mexico. Yale has received a total of $ 50,000 in cash to date.

To earn a 70 % interest in the Carol property El Condor will be required to spend $ 1,700,000 on exploration expenditures and pay Yale a total of $350,000 over four years. The exploration expenditures required in the first year is $200,000 with $100,000 being a firm commitment having to be spent within the first six months.
El Condor will be designated as the operator for the project during the length of the Agreement and as such will oversee the work on the property and designate contractors, which may include Minera Alta Vista, Yale�s Mexican subsidiary.
About Yale Resources:
Yale Resources is an exploration and development company concentrating in northwestern Mexico. Utilizing the joint venture business model, Yale is able to maximize its exposure to discovery while minimizing exploration risk. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects. Yale has four projects under option to value added partners with commitments for approximately $1.0M in expenditures during the next 12 months.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President

For additional information on Yale Resources please call the Company at 604-678-2531.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.

Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
604-678-2531

Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.

Security Stocks; Three-year contract extension worth $3 million (TSX-V: UZZ)

Edmonton, Alberta CANADA - February 22, 2011 (InvestorIdeas.com Newswire) - United Protection Security Group Inc. (UZZ - TSX Venture), (UPSG or the Company),is pleased to announce the signing of a three-year extension of a current contract to provide security services for a large Energy Provider in Alberta.

Fredy Ramsoondar, CEO states, "Our commitment of providing quality security services is key in not only winning new contracts, but having the trust of our current clients in extending current relationships going forward. The current global economic situation has reinforced how important it is to have the trust of our clients to continue our business relationship in protecting and safeguarding their assets."
Due to the nature of the security services provided, the Company is not at liberty to disclose the name of its client.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V: UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts.
For additional investor and media relations inquiries contact:
Fredy Ramsoondar CEO and Director
Email: fredy.ramsoondar@unitedprotection.com
Tel: 780-465-8101
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
The TSX Venture Exchange has neither approved nor disapproved the information contained herein.
United Protection Security Group Inc.
#212, 8711A - 50th Street,
Edmonton, Alberta T6B 1E7
Source: United Protection Security Group Inc. (TSX-V: UZZ) http://www.unitedprotection.com
Maximum News Dissemination by Filing Services Canada Inc. http://www.usetdas.com
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.

Wind News; Taller Wind Towers for GE (NYSE: GE) and Clean Wind Energy Tower (OTC: CWET)

Point Roberts, WA - February 22, 2011 - Investorideas.com, a leader in cleantech stock research issues a sector close-up on wind stocks and how two companies are betting on taller wind towers for better efficiencies.

GE (NYSE: GE) recently reported the acquisition of next generation technology from Wind Tower Systems, LLC (WTS) that is expected to enable taller wind turbine towers. According to the press release,: The need for taller, cost-efficient towers is becoming an important factor in the wind industry as blade lengths increase. "
Wind company Clean Wind Energy Tower, Inc (OTCBB:CWET) may be working on one of the tallest wind towers, with a very unique technology . According to Ronald W. Pickett, President and CEO, Chairman, " We create a downdraft inside our tower and the wind spins turbines constantly unlike wind farm turbines on a tower pole which sit and wait for wind to blow.”
Clean Wind Energy, Inc. a wholly owned subsidiary of Clean Wind Energy Tower, Inc, (OTCBB:CWET) is designing and preparing to develop, and construct large "Downdraft Towers” that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity.
The Downdraft Tower is a hollow cylinder with a water spray system at the top. Pumps deliver water to the top of the Downdraft Tower to spray a fine mist across the entire opening. The water evaporates and cools the hot dry air at the top. The cooled air is more dense and heavier than the outside warmer air and falls through the cylinder at speeds up to 50 mph, driving the turbines located at the base of the structure. The turbines are attached to generators to produce electricity. The exterior of the Downdraft Tower is constructed with vertical "wind vanes” that run the entire length of the structure. The Downdraft Tower's vanes capture the prevailing wind and channel it through a separate system of tunnels to turn turbines attached to generators that produce additional electrical power. This dual renewable energy resource enhances the capability and productivity of the Clean Wind system.
The Downdraft Tower has the capability of being operated with virtually no carbon footprint, fuel consumption, or waste production and this technology has the potential to generate clean, cost effective and efficient electrical power without the damaging effects caused by using fossil or nuclear fuels, and other conventional power sources. The Company also believes that increasing emphasis on green technologies and governmental incentives in the energy industry should have a positive long-term effect on the Company's planned business and the wind energy industry in general.
The Company has entered into a number of agreements with potential partners to meet the development aspects of the tower. Specifically, three of the largest companies in the world are working with clean wind providing final bids to meet the tower's specifications.
More info : www.cleanwindenergytower.com
GE Completes Acquisition of Next-Generation Wind Turbine Tower Technology Technology Designed to Allow Taller Towers while Lowering Wind Farm Installation and Transportation Costs
SCHENECTADY , N.Y. - 11 February 2011 - GE (NYSE: GE) announced today the acquisition of next generation technology from Wind Tower Systems, LLC (WTS) that is expected to enable taller wind turbine towers. The need for taller, cost-efficient towers is becoming an important factor in the wind industry as blade lengths increase.
WTS has been working on the development of the space frame tower system technology for use at wind farm sites that require hub heights of 100 meters or more. The space frame tower technology is a highly engineered and optimized structure that will handle the unique static and dynamic loads generated by wind turbines.
WTS also has been developing innovative ways to transport and install these taller wind turbine towers. The space frame technology will use standard flatbed trucks. Hi Jack system technology can eliminate the need for heavy lift cranes during installation. These new technologies offer the ability to cost effectively extend the tower height, which in turn enables the turbine to produce more energy.
"We see great potential in the addition of this technology to our portfolio not only for our customers but also for the wind industry as a whole,” said Victor Abate, vice president-renewable energy for GE Power & Water. "Taller towers are an essential complement to longer blades. Longer blades capture more energy and in turn improve return on investment for wind farm developers.”
"The taller space frame towers and integrated lifting system concepts, developed with the support of the U.S. DOE and California Energy Commission, have been designed to drive lower wind energy costs,” said Thomas Conroy, CEO of Wind Tower Systems. ”We are delighted that the development of the company's products will be completed and commercialized by GE.”
Plans are underway to install a prototype of the GE's space frame tower system technology to validate and test its design later this year with commercial availability targeted for 2012.
GE (NYSE: GE) is an advanced technology, services and finance company taking on the world's toughest challenges. Dedicated to innovation in energy, health, transportation and infrastructure, GE operates in more than 100 countries and employs about 300,000 people worldwide. For more information, visit the company's Web site at www.ge.com.
Learn more about Clean Wind Energy Tower, Inc. (OTCBB: CWET) at Investorideas.com : http://www.investorideas.com/CO/CWE/
Contact Clean Wind:
410 972 4713
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Sign up at Investor Ideas for free investor alerts including news on Clean Wind Energy Tower : http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month in addition to 100,000 144 shares for 4 months ) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information about Investorideas.com
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Source: www.RenewableEnergyStocks.com, www.Investorideas.com, Clean Wind Energy Tower, Inc. (OTCBB: CWET)

Security Stocks; Visualant (OTCBB:VSUL) Senior Management Articulates Japan Growth Strategy

SEATTLE - February 22, 2011 (Investorideas.com Defense Newswire) - Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading color based identification and diagnostic solutions announced today that senior management of the Company, working with two members of the Visualant Board of Directors from Japan, have outlined the strategy for introducing the Visualant Spectral Pattern Matching ("SPM") technology to the Japanese market.

The Japanese directors will work with the Company to initiate a Visualant Co Ltd, a Japanese subsidiary corporation, which will enter into a master license agreement to the Visualant SPM technology for the Japanese market. The Visualant KK will work to license the Visualant SPM technology to strategic Japanese partners. In addition, the Visualant KK will seek Japanese technology to distribute in North America through Visualant's TransTech distribution subsidiary.
Visualant's Japanese directors, Dr. Masahiro Kawahata, a respected scientist, and Mr. Tom Arai, a respected businessman, have been instrumental in making introductions to potential Japanese partners. They will continue their efforts on Visualant's behalf.
Visualant CEO Ron Erickson said, "We applaud the efforts of both Dr. Kawahata and Mr. Arai. They have been of invaluable assistance as we work to introduce the Visualant SPM technology to the Japanese market."
About Visualant, Inc.
Visualant, Inc. develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Its patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching (SPM). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com

Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs. (2500 per month)

Biotech/Pharma Stock News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) to Present at Citi Global Health Care Conference

LINCOLNSHIRE, Ill. - February 22, 2011 (Investorideas.com newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will be presenting at the 2011 Citi Global Health Care Conference. The conference will take place March 1-3, 2011 at the Hilton Hotel in New York City, New York.

Stephen M. Simes, BioSante�s president & CEO, will speak Tuesday, March 1, 2011 at 2:30 pm EST. He will provide an overview of the company, as well as an update on the LibiGel® (testosterone gel) Phase III clinical development program. A live audio webcast of Mr. Simes� remarks may be accessed at: http://www.veracast.com/webcasts/citigroup/healthcare2011/88112623.cfm. A webcast replay will be available one hour after conclusion of the presentation and will expire June 1, 2011.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com

Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com (1000 per month).

Consumer/ Retail Stocks; YesDTC (OTCBB:YESD) to Distribute NutriFusion in Up to 300 Mannings Drug Stores in Asia

SAN FRANCISCO - February 22, 2011 (Investorideas.com newswire) � YesDTC Holdings, Inc. (OTCBB:YESD), a direct-to-consumer marketer and global distributor of consumer goods and products today announced its Asian operating division, YesDTC Asia Ltd., has reached an agreement with Mannings Drugs in Hong Kong to distribute the NutriFusion nutraceutical supplement product in up to 300 stores. Earlier this year, YesDTC announced it will serve as the exclusive direct-to-consumer and retail distributor for this product throughout the world. Mannings is well known in Hong Kong as the highly popular health and beauty chain with the most extensive network of drug store locations, recognized as the "No.1 Most Preferred Brand" for seven consecutive years (2004-2010) in key market surveys.

"This is a tremendous opportunity for us to further penetrate the Asian markets," commented Joseph Noel, CEO of YesDTC. "NutriFusion will join PureSleep as our second Asian initiative, both of which we believe hold tremendous revenue generating potential. We have already designed new Chinese packaging and are very close to finalizing print advertisements that will support this new retail effort. We expect it to be on store shelves over the next two months."
Mr. Noel continued, "We are quickly realizing that Chinese consumers place a very high value on ultra-premium quality, American-made products. NutriFusion has received FDA GRAS certification, whereas many vitamin products on Chinese store shelves today actually have questionable ingredients and no government oversight certifications. We believe Chinese consumers will take great comfort in knowing that they can receive important vitamins and phytochemicals in a product made from 100% California grown fruits and vegetables. We are also finding an extremely high level of interest in our FDA-cleared PureSleep anti-snoring product due to its being manufactured from 100% American made composite plastic materials, unlike other competing devices on the market today that have no governmental clearances and are manufactured using Chinese produced plastics." He concluded, "With a vastly superior product that will be offered at a similar price point, we believe our PureSleep marketing initiative can be highly successful and profitable for our Company and its shareholders."
NutriFusion is an easy-to-consume capsule and chewable nutraceutical supplement product containing food-based supplements derived from 100% California grown fruits and vegetables. To achieve its premium nutritional results, NutriFusion utilizes patented freeze dried technology that prevents oxidation and degradation of the supplement. This process preserves and retains the natural vitamins, minerals and phytochemicals that comprise the important, vital nutrients contained in fruits and vegetables. Each NutriFusion capsule provides the equivalent nutrition of five servings of fruits and vegetables.
YesDTC's growing product portfolio currently includes the NutriFusion line of easy-to-consume capsule and chewable nutraceutical supplement products; WordSmart, the knowledge and vocabulary building program sponsored by Alex Trebek of Jeopardy!; PureSleep Asia, the U.S. FDA-cleared anti-snoring dental device for the treatment of snoring; SimplyMusic(TM), the playing-based music education system; and MediPendant(TM), the only speak and listen through the pendant medical alarm system. The Company's infomercials for WordSmart and MediPendant can be seen at the following links, respectively, http://www.vimeo.com/16363930 and www.medipendant.com. More information on NutriFusion can be seen at www.nutrifusion.com and SimplyMusic at www.simplymusic.com
About YesDTC Holdings, Inc.
YesDTC Holdings, Inc. is a direct-to-consumer marketing company specializing in direct response television (DRTV), internet and retail marketing programs. The Company brings a unique set of skills to this market space. YesDTC combines both the creative talents and financial acumen needed to create a total package for direct-to-consumer marketing programs. Importantly, the Company also maintains a strategic partnership with Schulberg Media Works (SMW), a pioneering media production firm in the direct-to-consumer space with a highly acclaimed list of successful client campaigns and product infomercials. SMW's track record is impressive, with nearly $1.0 billion in revenues generated and a high profile list of industry awards and recognitions. Specifically, SMW campaigns include Tempur-Pedic, Guthy-Renker, Sony, 24-Hour Fitness, Rhino Records, HarperCollins and PureSleep, among many others. More information on YesDTC Holding can be found at www.yesdtc.com and additional information on Schulberg Media Works can be found at www.smw.tv.
Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.
Contact:
YesDTC Holdings, Inc
Christian Kirsebom
(925) 247-6666
Contact Investorideas.com
dvanzant@investorideas.com
Visit the YESD showcase profile at Investorideas.com
http://www.investorideas.com/CO/YESD/
Request News and Info on YESD
Disclosure, Disclaimer/ YESD is a paid advertising client on Investorideas.com.
YESD: one time fee of five thousand cash and three hundred thousand 144 shares
About Investorideas.com
- Investor Ideas the can change the world

Sign up for free stock alerts and news:
http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer: The following news is paid for and /or published as information only for our readers. Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics
Investor Protection and Regulation for Pinks sheets: http://www.pinksheets.com/otcguide/investors_protection.jsp